Lamivudine Unknown Status Phase 3 Trials for Chronic HBV With Severe Exacerbation Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01848743Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation